The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human, phase I study of CBP-1008, a first-in-class bispecific ligand drug conjugate (Bi-XDC), in patients with advanced solid tumors.
 
Ning Li
No Relationships to Disclose
 
Jifang Gong
No Relationships to Disclose
 
Jian Zhang
No Relationships to Disclose
 
Dan Liu
No Relationships to Disclose
 
Yaqing Chen
No Relationships to Disclose
 
Youzhong Zhang
No Relationships to Disclose
 
Yi Huang
No Relationships to Disclose
 
Jing Wang
No Relationships to Disclose
 
Jie Tang
No Relationships to Disclose
 
Guiling Li
No Relationships to Disclose
 
Ying Wang
No Relationships to Disclose
 
Junyan Wu
No Relationships to Disclose
 
Suxia Luo
Consulting or Advisory Role - KYM Biosciences
 
Ge Lou
No Relationships to Disclose
 
Wei Duan
No Relationships to Disclose
 
Robert Huang
No Relationships to Disclose
 
Mo Xu
No Relationships to Disclose
 
Xichun Hu
No Relationships to Disclose
 
Lingying Wu
No Relationships to Disclose
 
Lin Shen
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD; SERVIER; Transcenta Holding Limited
Research Funding - BeiGene (Inst)